USPTO serial 77755345
TARGET HEALTH GLOBAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOWRY, LEIGH A
- Law office
- TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TARGET HEALTH GLOBAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth I. Kohn
KENNETH I. KOHN KOHN & ASSOCIATES, PLLC30500 NORTHWESTERN HWY STE 410FARMINGTON HILLS, MI 48334-3179UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Data processing services; Providing statistical information for business or commercial purposes; Business auditing services; data processing services in the biostatistics field; Performing statistical analysis for business purposes; Manufacturer representatives in the field of pharmaceuticals; development of business processes for the analysis and implementation of clinical trials dealing with pharmaceutical drug development | ACTIVE | May 1, 2009 |
| 042 | Providing online computer database for use in gathering and providing clinical trial data regarding medical and scientific research; Scientific research; Technical consultation and research in the medical and pharmaceutical fields; Product research and development; medical and scientific research services in the field of treatment and diagnosis provided for medical service providers; Technical writing for others; Providing quality assurance services in the field of pharmaceuticals; troubleshooting of product and process development problems dealing with safety and regulatory toxicology programs as it relates to medical and scientific research in the development of pharmaceutical drugs; Medical and scientific research, namely, conducting clinical trials; Consultation in the fields of pharmaceutical drug development, conducting clinical trials; consultation in the fields of pharmaceutical drug development, namely, consulting with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements and evaluate available and competitive technologies; development of pharmaceutical product processes for others; Technical writing for others, namely, writing integrated clinical and statistical study reports and regulatory manuscripts related to medical and scientific research in the development of pharmaceutical drugs, as an intedgrated component; compiling patient records and patient data via a global computer information network for research purposes in the field of medical science and medical consultancy | ACTIVE | May 1, 2009 |
| 045 | Reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; legal consulting services regarding Food and Drug law and regulation compliance, namely, consulting in the preparation of legal negotiations, in the preparation of legal documents and forms required by the FDA, in the preparation of responses to FDA questions and warning letters, and the follow-up with FDA on post application submission questions, in the preparation of meetings with legal counsel; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical products; technical writing for other, namely, writing regulatory compliance manuscripts in the field of pharmaceutical clinical trials | ACTIVE | May 1, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2011 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 9, 2011 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 1, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 1, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 9, 2011 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 23, 2010 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 23, 2010 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 23, 2010 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 30, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2010 | PGRR | PETITION GRANTED - RESPONSE RECEIVED | — |
| Jun 28, 2010 | TPET | TEAS PETITION TO REVIVE RECEIVED | — |
| May 24, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 23, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 23, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2010 | ALIE | ASSIGNED TO LIE | — |
| Apr 12, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2009 | NWAP | NEW APPLICATION ENTERED | — |